ArticleNagoya journal of medical science2018

Assessment of tumor response to neoadjuvant chemotherapy in patients with breast cancer using MRI and FDG-PET/CT-RECIST 1.1 vs. PERCIST 1.0.

Kazuhiro Kitajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.